Literature DB >> 8505006

Risk of damage to the cervix by dilatation for first-trimester-induced abortion by suction aspiration.

A Molin1.   

Abstract

A fall in cervical resistance to dilatation for first-trimester-induced abortions has been observed in previous studies and considered a sign of tearing of the cervical tissue. In a study of 104 patients undergoing first-trimester abortion a fall in resistance was found in 12.5% of women in whom the cervix was dilated to 9 mm, and in 66.7% when dilatation reached 11 mm. No difference between parous and nulliparous women was found.

Entities:  

Keywords:  Abortion, Induced; Biology; Cervical Dilatation--complications; Cervix; Clinical Research; Developed Countries; Europe; Family Planning; Fertility Control, Postconception; Genitalia; Genitalia, Female; Northern Europe; Physiology; Pregnancy; Pregnancy, First Trimester; Reproduction; Research Methodology; Research Report; Scandinavia; Sweden; Treatment; Urogenital System; Uterus; Vacuum Aspiration

Mesh:

Year:  1993        PMID: 8505006     DOI: 10.1159/000292688

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

1.  Malaria, intestinal helminths and other risk factors for stillbirth in Ghana.

Authors:  Nelly J Yatich; Ellen Funkhouser; John E Ehiri; Tsiri Agbenyega; Jonathan K Stiles; Julian C Rayner; Archer Turpin; William O Ellis; Yi Jiang; Jonathan H Williams; Evans Afriyie-Gwayu; Timothy Phillips; Pauline E Jolly
Journal:  Infect Dis Obstet Gynecol       Date:  2010-04-01

2.  Role of sublingual misoprostol for cervical priming in first trimester medical termination of pregnancy.

Authors:  Megha Mathur; Jyotsna Rani
Journal:  J Clin Diagn Res       Date:  2014-08-20

3.  Characterization of cervical canal and vaginal bacteria in pregnant women with cervical incompetence.

Authors:  Meiguo Sun; Huiwu Geng; Jingjing Bai; Jiahui Feng; Na Xu; Yunlong Liu; Xiaoying Liu; Gang Liu
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.